Relaxin-3 receptor (Rxfp3) gene deletion reduces operant sucrose-but not alcohol-responding in mice
AW Walker, CM Smith, AL Gundlach, AJ Lawrence
Genes, Brain and Behavior | WILEY-BLACKWELL | Published : 2015
Related Projects (4)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
This research was supported by National Health and Medical Research Council (NHMRC) of Australia project grants (1021227 and 1079893 to A.J.L. and A.L.G.) and Research Fellowships (1020737 and 1005985) to A.J.L. and ALG; a grant from the Pratt and Besen Foundations and the Victorian Government's Operational Infrastructure Support Program. A.W.W. was the recipient of University of Melbourne International Postgraduate Research Scholarships (APA/IPRS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank Dr Timothy Lovenberg (Neuroscience Drug Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson) for commissioning the production of the Rxfp3 KO strain and providing the Florey Institute of Neuroscience and Mental Health (A.L.G.) with an original breeding colony.